Overview


According to FutureWise analysis the market for antimycotics is expected to reach US$ 21.82 billion by 2031 at a CAGR of 4.22%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Antimycotics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Antimycotics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Antimycotics, also known as antifungal drugs, are used to destroy or inhibit the growth of fungi that cause infections. An antifungal agent is a medication that selectively destroys fungal pathogens from a host with minimal toxicity to the host. There are different types of antifungal drugs that treat fungal infections. Fungi can cause various conditions. Most of them affect the nails and skin, causing rashes or other skin problems, but some can cause more serious infections. Fungi can also cause meningitis, blood infections, and lung infections. Antifungal drugs target structures or functions essential in fungal cells without affecting those of human cells. This allows the body to resist a fungal infection without damaging the body's cells. 

Several formulation strategies are used for delivering antimycotic compounds through the targeted skin site, including systemic antimycotics, oral antimycotics, topical antimycotics, and others. Topical treatment for fungal infections offers several benefits including, targeting the site of infection, lowering the risk of systemic side effects, improving the effectiveness of treatment and, high patient compliance. Different types of topical effective antifungal compounds have been used to treat various dermatological skin infections. The major classes of topical antifungals are polyenes, azoles, and allylamine/benzylamines. Cicloprox is an antifungal agent also used topically. These antifungal medications are commercially available in conventional dosage forms such as gels, creams, lotions, and sprays.

FutureWise Market Research has published a report that provides an insightful analysis antimycotics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, antimycotics market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Merck KGaA.
  • Thermo Fisher Scientific
  • Pfizer Inc.
  • Novartis AG
  • Sanofi S.A.
  • AstraZeneca plc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing prevalence of fungal infection and nosocomial infections is attributed to the confluence of several major factors, which are likely to drive the target market over the projection period. Firstly, the increasing geriatric population with a higher prevalence of immune-compromised individuals renders them more susceptible to such infections. Also, the rising incidence of diseases such as HIV/AIDS, chemotherapy, and organ transplants further weakens immune systems, making a fertile environment for fungal pathogens. In addition, technological advancements in surgical and transplant procedures further drive patient outcomes. The invasive nature of these procedures and extended hospital stays create surroundings where fungal microbes may grow. Antimycotics play a crucial role in serving as a line of defense against these infections. By offering targeted and effective standards of prevention and treatment, antimycotics safeguard patients experiencing complex medical treatments, thus contributing to the overall safety of advanced medical procedures. Also, increased investment in research and development to design novel and more effective antimycotic drugs potentially leads to a constant stream of innovative products introduced into the market, further propelling the market growth. However, factors such as toxicity, development of resistant strains, interaction with different drugs, and time- and cost-consuming regular maintenance of the patients are expected to hinder the market growth. Concerns about drug toxicity and adverse side effects pose a significant hurdle to widespread adoption. Moreover, growing resistant fungal strains presents a major risk, thus reducing the effectiveness of existing antimycotics.

By Formulation Types

  • Systemic Antimycotics
  • Oral Antimycotics
  • Intravenous Antimycotics
  • Intra-vaginal Antimycotics
  • Topical Antimycotics

By End User

  • Hospitals
  • Diagnostic Laboratories and Centers
  • Academic and Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to the rise in incidences of fungal and nosocomial infections, rise in the number of cases of mucormycosis, presence of key players, development of the healthcare sector, rise in prevalence in clinical urgency to expand the usage of these drugs, and the existence of new anti-fungal drugs in the region is likely to boost the growth of antimycotics market over the forecast period. In addition, the increasing demand for OTC drugs and the presence of an established pharmaceutical industry, which is consistently seeking extensive commercialization of their drugs and improving their geographical reach, is further expected to escalate the growth of the regional market.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Antimycotics Market By Formulation Types, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Antimycotics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antimycotics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Antimycotics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Antimycotics Market, By Formulation Types Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Systemic Antimycotics
        2. Oral Antimycotics
        3. Intravenous Antimycotics
        4. Intra-vaginal Antimycotics
        5. Topical Antimycotics

  • 8.   Global Antimycotics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostic Laboratories and Centers
        3. Academic and Research Institutes

  • 9.   North America Antimycotics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Antimycotics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Antimycotics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Antimycotics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Merck KGaA.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Thermo Fisher Scientific
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Pfizer Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Novartis AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sanofi S.A.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. AstraZeneca plc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients